1620
E. Prifti et al. / Carbohydrate Research 346 (2011) 1617–1621
ꢀ89); 1H NMR (400 MHz, CDCl3): d 5.51 (d, 1H, J 5.0 Hz, H-1 Gal),
5.32–5.21 (m, 2H, H-2 and H-3 Rha), 5.07 (pt, 1H, J 7.9 Hz, H-4
Rha), 4.81 (d, 2H, J 0.9 Hz, H-1 Rha), 4.63 (dd, 2H, J 2.4, 7.9 Hz, H-
3 Gal), 4.36–4.26 (m, 2H, H-2 and H-4 Gal), 4.06–3.95 (m, 2H, H-5
Rha, H-5 Gal), 3.86 (dd, 3H, J 7.4, 9.6 Hz, H-6a Gal), 3.59 (dd. 3H, J
6.2, 9.6 Hz, H-6b Gal), 2.16 (s, 3H, Ac), 2.04 (s, 3H, Ac), 2.00 (s, 3H,
Ac), 1.56 (s, 3H, C(CH3)2), 1.44 (s, 3H, C(CH3)2), 1.34 (m, 6H,
C(CH3)2), 1.21 (d, 3H, J 6.3 Hz, H-6 Rha); 13C NMR (100 MHz, CDCl3):
d 109.2, 108.7 (C(CH3)2), 97.3 (C-1 Rha), 96.2 (C-1 Gal), 71.2, 70.8,
70.62, 70.58, 69.8, 69.2 (C-2, C-3, C-4 Rha and C-2, C-3, C-4 Gal),
66.3, 66.2 (C-5 Rha, C-5 Gal), 65.3 (C-6 Gal), 26.1, 26.0, 25.0, 24.4
(C(CH3)2), 21.0, 20.9, 20.8, 20.75 (CH3CO), 17.2 (C-6 Rha).
Rha), 91.1 (C-3 Api), 86.5 (C-2 Api), 76.2, 72.2 (C-2 and C-3 Rha),
73.5 (C-30 Api), 71.3 (C-4 Rha), 71.1 (C-4 Gal), 70.7 (C-3 Gal), 70.4
(C-2 Gal), 69.4 (C-4 Api), 66.9 (C-5 Gal), 66.3 (C-5 Rha), 60.4 (C-6
Gal), 26.0, 24.9, 24.5 (C(CH3)2), 21.1 (CH3CO), 20.8 (Ac), 19.4 (C-6
Rha); ESI MS: m/z 712.2 [M+NH4]+; calcd for C33H42O16ꢃNH4 712.72.
1.7. 6-O-(a-L-Rhamnopyranosyl)-D-galactopyranose (10)
Compound 7 (120 mg, 0.23 mmol) was dissolved in 90% aque-
ous CF3CO2H (1.5 mL), the solution was stirred for 15 min at
22 °C, toluene (5 mL) was added and solvents were evaporated in
vacuum. The residue was dissolved in toluene and concentrated
to dryness; this operation was repeated twice. The product
(95 mg), Rf = 0.44 (CH2Cl2–MeOH 9:1) was dissolved in dry MeOH
(1.0 mL), then 0.02 M NaOMe (1.0 mL) was added and after 1 h at
22 °C the reaction mixture was neutralised by addition of Amber-
lite IR120 (H+). The resin was removed by filtration, the filtrates
were concentrated in vacuum and the residue was freeze-dried
from water to give disaccharide 10 as white powder (59 mg,
1.5. 6-O-(4-O-Acetyl-2,3-O-carbonyl-b-
L-rhamnopyranosyl)-
1,2:3,4-di-O-isopropylidene- -galactopyranose (8)
a-D
Reaction of glycosyl acceptor 1 (300 mg, 1.15 mmol) with glyco-
syl bromide 3 (500 mg, 1.69 mmol) was carried out in the presence
of Ag2O (500 mg, 2.16 mmol) and MS 4 Å (3.0 g) in essentially the
same way as for the synthesis of 6. The product was purified by
column chromatography (toluene–acetone, 4:1) to give disaccha-
78%); 1H NMR (400 MHz, D2O): d 5.17 (d, J 3.6 Hz, H-1
a-Gal),
4.74 (br s, H-1 Rha), 4.48 (d, J 7.9 Hz, H-1 b-Gal), 1.21 (d, J 6.2 Hz,
ride 8 (390 mg, 72%); ½a D20
ꢂ
ꢀ16 (c 1.0, CHCl3) (lit.12
[
a]
D
ꢀ10.2);
H-6 Rha); 13C NMR (100 MHz, D2O) d 100.6, 100.4 (JC–H 175.8 Hz,
1H NMR (CDCl3, 400 MHz): d 5.51 (d, 1H, J 5.0 Hz, H-1 Gal), 5.42
(m, 1H, H-4 Rha), 4.97 (br s, 1H, H-1 Rha), 4.78 (m, 2H, H-2 and
H3 Rha), 4.62 (dd, 1H, J 7.9, 2.4 Hz, H-3 Gal), 4.31 (dd, 1H, J 5.0,
2.4 Hz, H-2 Gal), 4.29 (dd, 2H, J 7.9, 2.0 Hz, H-4 Gal), 4.02 (m, 1H,
H-5 Gal), 3.94 (dd, 1H, J 9.8, 6.1 Hz, H-6a Gal), 3.79–3.72 (m, 2H,
H-5 Rha, H-6b Gal), 2.11 (s, 3H, Ac), 1.54 (s, 3H, C(CH3)2), 1.43 (s,
3H, C(CH3)2), 1.35 (s, 3H, C(CH3)2), 1.33 (s, 3H, C(CH3)2), 1.29 (d,
3H, J 6.3 Hz, H-6 Rha); 13C NMR (100 MHz, CDCl3): d 169.0 (CH3CO),
153.6 (C@O), 109.2, 108.8 (C(CH3)2), 96.2 (C-1 Gal), 95.5 (C-1 Rha),
76.3, 72.5 (C-2 and C-3 Rha), 71.4 (C-4 Rha), 70.7, 70.55, 70.5 (C-2,
C-3 and C-4 Gal), 70.2 (C-5 Rha), 67.4 (C-6 Gal), 66.1 (C-5 Gal), 26.1,
26.0, 25.0, 24.4 (C(CH3)2), 20.8 (CH3CO), 19.4 (C-6 Rha); ESI MS: m/z
497.4 [M+Na]+; calcd for C21H30O12Na 497.44.
C-1 Rha), 96.4 (C-1 b-Gal), 92.3 (C-1 a-Gal), 73.4, 72.7, 72.0, 71.8,
70.2, 70.0, 69.9, 69.4, 69.1, 69.0, 68.8, 68.6, 68.2; HRESI MS: m/z
349.1104 [M+Na]+; calcd for C12H22O10Na 349.1105.
1.8. 6-O-(b-L-Rhamnopyranosyl)-D-galactopyranose (11)
Treatment of compound 8 (103 mg, 0.22 mmol) as described for
synthesis of 10, afforded disaccharide 11 as white powder (68 mg,
95%); 1H NMR (D2O, 400 MHz): d 5.14 (br s, H-1
a-Gal), 4.56 (br s,
H-1 Rha), 4.47 (d, 2H, J 7.9 Hz, H-1 b-Gal), 1.18 (m, H-6 Rha); 13C
NMR (100 MHz, D2O) d 99.9, 99.7 (C-1 Rha), 96.5 (C-1 b-Gal),
92.4 (C-1
12H22O10Na 349.1105.
a
-Gal), HRESI MS: m/z 349.1105 [M+Na]+; calcd for
C
1.6. 6-O-(3-C-(4-O-Acetyl-2,3-O-carbonyl-b-
oxymethyl)-2,3-O-(R)-benzylidene-b- -erythrofuranosyl)-
1,2:3,4-di-O-isopropylidene- -galactopyranose (9)
L
-rhamnopyranosyl-
1.9. 6-O-(3-C-(b-
erythrofuranosyl)-
L
-Rhamnopyranosyloxymethyl)-b-
-galactopyranose (12)
D-
D
D
a-D
A soln of disaccharide 9 (35 mg, 50 lmol) in 90% aqueous
A mixture of glycosyl acceptor 1 (33.9 mg, 0.13 mmol), disac-
charide donor 2 (72.8 mg, 0.13 mmol), NIS 35.2 mg (0.16 mmol)
and MS 4 Å (100 mg) in CH2Cl2 (4 mL) was stirred for 30 min at
ꢀ20 °C, then HClO4/SiO2 (7 mg, prepared according to14b) was
added and the stirring continued for 30 min at ꢀ20 to 0 °C. The
reaction was quenched with addition of Et3N (0.1 ml), the mixture
was diluted with CH2Cl2 and filtered. The filtrates were washed
with 10% aqueous Na2S2O3, satd NaHCO3 and water, organic layer
was dried and concentrated. TLC analysis of the residue indicated
the presence of two products, the first having Rf = 0.51 and the sec-
ond having Rf = 0.32 (hexane–EtOAc 3:7), which were separated by
column chromatography (hexane–EtOAc 7:3?3:7). The first com-
CF3CO2H (1.8 mL) was stirred for 15 min at 22 °C and then concen-
trated in vacuo several times with toluene (5 mL). The residue was
dissolved in EtOH–EtOAc (1:1), cat. 10% Pd/C was added and the
mixture was stirred under H2 for 17 h at 22 °C. The catalyst was fil-
tered off, solvents were evaporated under vacuum and the residue
was treated with 0.1 M NaOMe in MeOH for 2 h at 22 °C. The mix-
ture was neutralised with Amberlite IR-120 (H+), the resin was fil-
tered off and filtrates were concentrated. The residue was purified
using gel permeation chromatography (Toyopearl HW-40S,
1.5 ꢄ 80 cm) in H2O and the product was freeze-dried to give the
title compound 12 as a white powder (9 mg, 39%): 1H NMR
(400 MHz, CDCl3): d (D2O, 600 MHz): d 5.10 (H-1
a-Gal), 4.95,
pound was identified as trisaccharide 12 (34.3 mg, 38%), ½a D20
ꢂ
4.88 (H-1 Api), 4.51 (H-1 Rha), 4.49 (H-1 b-Gal), 1.15 (H-6 Rha);
ꢀ45 (c 1.0, CHCl3); 1H NMR (400 MHz, CDCl3): d 7.56 (m, 2H, Ph),
7.37 (m, 3H, Ph), 5.95 (s, 1H, CHPh), 5.55 (d, 1H, J 5.1 Hz, H-1
Gal), 5.41 (m, 1H, H-4 Rha), 5.28 (s, 1H, H-1 Api), 5.12 (br s, 1H,
H-1 Rha), 4.77 (m, 2H, H-2 and H-3 Rha), 4.61 (dd, 1H, J 7.9,
2.4 Hz, H-3 Gal), 4.49 (s, 1H, H-2 Api), 4.32 (dd, 1H, J 5.1, 2.4 Hz,
H-2 Gal), 4.21 (dd, 1H, J 7.9, 1.9 Hz, H-4 Gal), 4.18 (d, 1H, J
11.1 Hz, H-4a Api), 4.14–4.09 (m, 3H, H-30a Api, H-6a and H-6b
Gal), 4.03 (m, 1H, H-5 Gal), 4.00 (d, 1H, J 10.3 Hz, H-30b Api), 3.89
(d, 1H, J 11.1 Hz, H-4b Api), 3.76 (m, 1H, H-5 Rha), 2.04 (s, 1H,
Ac), 1.55 (s, 3H, C(CH3)2), 1.45 (s, 3H, C(CH3)2), 1.33 (s, 6H,
C(CH3)2), 1.30 (d, 2H, J 6.3 Hz, H-6 Rha); 13C NMR (100 MHz,
CDCl3): d 168.9 (CH3CO), 153.4 (C@O), 136.4, 129.8, 128.3, 127.4
(Ph), 106.8 (C-1 Api), 106.4 (PhCH), 96.3 (C-1 Gal), 95.1 (C-1
13C NMR (150 MHz, D2O) d 108.7 (C-1 Api), 100.3 (C-1 Rha), 96.4
(C-1
a-Gal), 92.2 (C-1 b-Gal), 16.6 (C-6 Rha); HRESI MS: m/z
481.1526 [M+Na]+; calcd for C17H30O14Na 481.1528.
1.10. Typical procedure for derivatisation of oligosaccharide
samples with APTS
An oligosaccharide (ꢁ0.2
ring in a solution prepared by mixing of 0.2 M APTS in 15% AcOH
(5 l) and 1 M NaBH3CN in THF (5 l). The resulting solution was
lmol) was solubilised by vigorous stir-
l
l
incubated for 20 h at 37 °C and APTS-derivatised product was sep-
arated from unreacted oligosaccharide using gel electrophoresis.17
A band corresponding to the APTS-derivatised oligosaccharide